Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

B. Bussel, James; Cheng, Gregory; N. Saleh, Mansoor; Psaila, Bethan; Kovaleva, Lidia; Meddeb, Balkis; Kłoczko, Janusz; Hassani, Habib; Mayer, Bhabita; L. Stone, Nicole; Arning, M.; Provan, Drew; Jenkins, J.M.

doi:10.1056/nejmoa073275

Public

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

Published in New England Journal of Medicine • Nov 28, 2007

Authors:

James B. Bussel

Gregory Cheng

Mansoor N. Saleh

Abstract

BACKGROUND: The pathogenesis of chronic idiopathic thrombocytopenic purpura (ITP) involves antibody-mediated platelet destruction and reduced platelet production. Stimulation of platelet production may be an effective treatment for this disorder. METHODS: We conducted a trial in which 118 adults wit...

Subject

Eltrombopag

Medicine

Platelet

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!